Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy
Clinical trial NCT00002449 · UNKNOWN
Trial details
- NCT number
- NCT00002449
- Sponsor
- Chiron Corporation
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1999-08-01
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.